Patient-Specific Embryonic Stem Cells Derived from Human SCNT Blastocysts.by: Woo Suk S Hwang, Sung Il I Roh, Byeong Chun C Lee, Sung Keun K Kang, Dae Kee K Kwon, Sue Kim, Sun Jong J Kim, Sun Woo W Park, Hee Sun S Kwon, Chang Kyu K Lee, Jung Bok B Lee, Jin Mee M Kim, Curie Ahn, Sun Ha H Paek, Sang Sik S Chang, Jung Jin J Koo, Hyun Soo S Yoon, Jung Hye H Hwang, Youn Young Y Hwang, Ye Soo S Park, Sun Kyung K Oh, Hee Sun S Kim, Jong Hyuk H Park, Shin Yong Y Moon, Gerald Schatten
Science (19 May 2005)
|
Reviews
[Write a review of this article]
There are no reviews of this article
Notes for this article2004년 논문이 가짜니까 2005년 논문도 자연히 가짜가 되었네
Find related articles from these CiteULike users
Find related articles with these CiteULike tags
AbstractPatient-specific, immune-matched human embryonic stem cells (hESC) are anticipated to be of great biomedical importance for studies of disease and development, and to advance clinical deliberations for stem cell transplantation. Eleven hESC lines were established by nuclear transfer (SCNT; NT) of skin cells from patients with disease or injury into donated oocytes. These lines (NT-hESCs), grown on human feeders from the same NT-donor or genetically-unrelated individuals, were established at high rates, regardless of NT-donor sex or age. NT-hESCs were pluripotent, chromosomally normal, and match NT-patient's DNA. Major Histocompatibility Complex (MHC) identity of each NT-hESC with the patient's showed immunological compatibility, important for eventual transplantation. With the generation of these NT-hESCs, evaluations of genetic and epigenetic stability can be made. Additional work remains regarding the development of reliable directed differentiation and the elimination of remaining animal components. Prior to clinical use of these cells, preclinical evidence is required to prove that transplantation of differentiated-NT-hESCs can be safe, effective and tolerated.
BibTeX record
RIS record